FDA to Review BLA for Oral Immunotherapy AR101 for Peanut Allergy By Steve Duffy Digital Content Editor Publish Date March 18, 2019
FDA to Review Higher Dose Naloxone Injection for Opioid Overdose Treatment By Da Hee Han, PharmD Publish Date March 15, 2019
Nalmefene HCl Injection Fast-Tracked for Emergency Treatment of Opioid Overdose By Diana Ernst, RPh Publish Date March 13, 2019
NDA for Novel Migraine Treatment Ubrogepant Accepted for FDA Review By Da Hee Han, PharmD Publish Date March 11, 2019
FDA to Review Lemborexant NDA for Treatment of Insomnia By Da Hee Han, PharmD Publish Date March 11, 2019
Descovy Non-Inferior to Truvada in Phase 3 HIV PrEP Study By Diana Ernst, RPh Publish Date March 7, 2019
Rapastinel Fails to Meet Primary Endpoint in Phase 3 Adjunctive MDD Trials By Diana Ernst, RPh Publish Date March 7, 2019
Emgality sBLA Gets Priority Review for Preventive Treatment of Episodic Cluster Headache By Diana Ernst, RPh Publish Date March 5, 2019
FDA to Review Fedratinib for the Treatment of Myelofibrosis By Steve Duffy Digital Content Editor Publish Date March 5, 2019
FDA to Review Diroximel Fumarate for Treatment of Relapsing Forms of MS By Diana Ernst, RPh Publish Date February 26, 2019
Soliris Gets Priority Review for Rare, Complement-Mediated CNS Disorder By Diana Ernst, RPh Publish Date February 25, 2019
Eptinezumab BLA Submitted for Episodic, Chronic Migraine Prevention By Steve Duffy Digital Content Editor Publish Date February 22, 2019
Xipere Under FDA Review for Macular Edema Associated With Uveitis By Da Hee Han, PharmD Publish Date February 20, 2019
FDA to Review IV, Oral Lefamulin for Community-Acquired Bacterial Pneumonia By Da Hee Han, PharmD Publish Date February 20, 2019
Chronic Low Back Pain Study Results Indicate Benefit With Tanezumab By Diana Ernst, RPh Publish Date February 19, 2019
Upadacitinib Gets FDA’s Priority Review for Treatment of Moderate to Severe RA By Diana Ernst, RPh Publish Date February 19, 2019
Intranasal Epinephrine Spray Granted Fast Track Designation By Steve Duffy Digital Content Editor Publish Date February 19, 2019
Seladelpar Granted Breakthrough Designation for Primary Biliary Cholangitis By Steve Duffy Digital Content Editor Publish Date February 19, 2019
Results From Bipolar I Disorder Trials Evaluating Brexpiprazole Announced By Da Hee Han, PharmD Publish Date February 15, 2019
